Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855 · see citing works

Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities

Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · see citing works

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · see citing works

Gene ontology analysis for RNA-seq: accounting for selection bias

Young, M. D., Wakefield, M. J., Smyth, G. K., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-2-r14 · Cited by 7,107 · see citing works

The PRIDE database and related tools and resources in 2019: improving support for quantification data

Pérez-Riverol, Y., Csordas, A., Bai, J.-W., Bernal-Llinares, M., Hewapathirana, S., Kundu, D. J., Inuganti, A., Griss, J., Mayer, G., Eisenacher, M., et al. (2018) · Nucleic Acids Res. · doi:10.1093/nar/gky1106 · Cited by 6,216 · see citing works

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · see citing works

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

circlize implements and enhances circular visualization in R

Gu, Z., Gu, L., Eils, R., Schlesner, M., & Brors, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu393 · Cited by 4,290 · see citing works

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143 · see citing works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works

NicheNet: Modeling intercellular communication by linking ligands to target genes

Browaeys, R., Saelens, W., & Saeys, Y. (2020) · Nature Methods · doi:10.1038/s41592-019-0667-5 · Cited by 2,192 · see citing works

New approach for understanding genome variations in KEGG

Kanehisa, M. I., Sato, Y., Furumichi, M., Morishima, K., & Tanabe, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky962 · Cited by 1,845 · see citing works

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · see citing works

Selected reaction monitoring for quantitative proteomics: a tutorial

Lange, V., Picotti, P., Domon, B., & Aebersold, R. H. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.61 · Cited by 1,396 · see citing works

Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase

Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · see citing works

Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics

Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., & Coon, J. J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.020131 · Cited by 1,288 · see citing works

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

Sia, D., Villanueva, A., Friedman, S., & Llovet, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,051 · see citing works

Organogenesis and development of the liver

Si-Tayeb, K., Lemaigre, F. P., & Duncan, S. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.01.011 · Cited by 800 · see citing works

Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis

Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784 · see citing works

Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain

Mo, A., Mukamel, E. A., Davis, F. P., Luo, C., Henry, G. L., Picard, S., Urich, M. A., Nery, J. R., Sejnowski, T. J., Lister, R., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.018 · Cited by 739 · see citing works

Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis

Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671 · see citing works

Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance

Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · see citing works

Pharmacological Inhibition of the Chemokine CCL2 (MCP-1) Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury

Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · see citing works

Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver

Remmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592 · see citing works

A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer

Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583 · see citing works

Target analysis by integration of transcriptome and ChIP-seq data with BETA

Wang, S., Sun, H., Ma, J., Zang, C., Wang, C., Wang, J., Tang, Q., Meyer, C. A., Zhang, Y., & Liu, X. S. (2013) · Nature Protocols · doi:10.1038/nprot.2013.150 · Cited by 544 · see citing works

H3K4me3 breadth is linked to cell identity and transcriptional consistency

Benayoun, B. A., Pollina, E. A., Ucar, D., Mahmoudi, S., Karra, K., Wong, E. D., Devarajan, K., Daugherty, A. C., Kundaje, A. B., Mancini, E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.027 · Cited by 536 · see citing works

DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.

Ahrens, M., Ammerpohl, O., von Schönfels, W., Kolarova, J., Bens, S., Itzel, T., Teufel, A., Herrmann, A., Brosch, M., Hinrichsen, H., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.004 · Cited by 528 · see citing works

An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis

Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523 · see citing works

The role of hepatokines in metabolism

Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · see citing works

Protein Aggregation Capture on Microparticles Enables Multipurpose Proteomics Sample Preparation*

Batth, T. S., Tollenaere, M. A. X., Rüther, P. L., González-Franquesa, A., Prabhakar, B. S., Bekker‐Jensen, S., Deshmukh, A. S., & Olsen, J. V. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.001270 · Cited by 448 · see citing works

Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis

Seidman, J. S., Troutman, T. D., Sakai, M., Gola, A., Spann, N. J., Bennett, H., Bruni, C. M., Ouyang, Z., Li, R. Z., Sun, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.001 · Cited by 443 · see citing works

Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver

Nathwani, A. C., Gray, J. T., Ng, C. Y., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball‐Cook, G., McIntosh, J., Boon‐Spijker, M., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4035 · Cited by 421 · see citing works

Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis

Dobie, R., Wilson-Kanamori, J. R., Henderson, B. E. P., Smith, J. R., Matchett, K. P., Portman, J. R., Wallenborg, K., Picelli, S., Zagorska, A., Pendem, S. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.024 · Cited by 420 · see citing works

Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413 · see citing works

A Simple Method for Gene Expression and Chromatin Profiling of Individual Cell Types within a Tissue

Deal, R. B., & Henikoff, S. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.013 · Cited by 379 · see citing works

A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma

Fujii, M., Shibazaki, Y., Wakamatsu, K., Honda, Y., Kawauchi, Y., Suzuki, K., Arumugam, S., Watanabe, K., Ichida, T., Asakura, H., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0016-1 · Cited by 355 · see citing works

Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease

du Plessis, J., van Pelt, J. F., Korf, H., Mathieu, C., der Schueren, B. V., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 324 · see citing works

Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

Moylan, C. A., Pang, H., Dellinger, A. E., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley‐Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2013) · Hepatology · doi:10.1002/hep.26661 · Cited by 316 · see citing works

ISMARA: automated modeling of genomic signals as a democracy of regulatory motifsPreprint

Balwierz, P. J., Pachkov, M. V., Arnold, P., Gruber, A. J., Zavolan, M., & van Nimwegen, E. (2014) · Genome Research · doi:10.1101/gr.169508.113 · Cited by 299 · see citing works

Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment

Clapper, J. R., Hendricks, M. D., Gu, G., Wittmer, C., Dolman, C. S., Herich, J., Athanacio, J., Villescaz, C., Ghosh, S. S., Heilig, J. S., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2013 · Cited by 294 · see citing works

Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis

Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R., & Henderson, N. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0304-x · Cited by 253 · see citing works

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250 · see citing works

Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis

Attanasio, M., Uhlenhaut, N. H., Sousa, V. H., O’Toole, J. F., Otto, E. A., Anlag, K., Klugmann, C., Treier, A.-C., Helou, J., Sayer, J. A., et al. (2007) · Nature Genetics · doi:10.1038/ng2072 · Cited by 240 · see citing works

Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis

Krenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D. P. P., Mossanen, J. C., Luedde, T., Trautwein, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318382 · Cited by 220 · see citing works

Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis

Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204 · see citing works

Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis

Rauch, A., Haakonsson, A., Madsen, J., Larsen, M., Forss, I., Madsen, M. R., Hauwaert, E. L. V., Wiwie, C., Jespersen, N., Tencerova, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0359-1 · Cited by 202 · see citing works

GIGGLE: a search engine for large-scale integrated genome analysis

Layer, R. M., Pedersen, B. S., DiSera, T., Marth, G., Gertz, J., & Quinlan, A. R. (2018) · Nature Methods · doi:10.1038/nmeth.4556 · Cited by 197 · see citing works

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis

Kita, Y., Takamura, T., Misu, H., Ota, T., Kurita, S., Takeshita, Y., Uno, M., Nagata, N., Kato, K., Ando, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043056 · Cited by 153 · see citing works

Signalling via the Osteopontin and High Mobility Group Box-1 Axis Drives the Fibrogenic Response to Liver Injury

Arriazu, E., Ge, X., Leung, T.-M., Magdaleno, F., Lopategi, A., Lu, Y., Kitamura, N., Urtasun, R., Theise, N., Antoine, D. J., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310752 · Cited by 144 · see citing works

Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers

Hasenfuss, S. C., Bakiri, L., Thomsen, M. K., Williams, E. G., Auwerx, J. H., & Wagner, E. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.018 · Cited by 140 · see citing works

Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes

Gressner, O. A., Lahme, B., Demirci, I., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.015 · Cited by 140 · see citing works

Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin

Lefebvre, P., Lalloyer, F., Baugé, E., Pawlak, M., Gheeraert, C., Dehondt, H., Vanhoutte, J., Woitrain, E., Hennuyer, N., Mazuy, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92264 · Cited by 117 · see citing works

ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma

Zheng, L., Xu, M., Xu, J., Wu, K., Fang, Q., Liang, Y., Zhou, S., Cen, D., Ji, L., Han, W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0399-y · Cited by 106 · see citing works

Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury

Terkelsen, M. K., Bendixen, S. M., Hansen, D., Scott, E. A. H., Moeller, A. F., Nielsen, R., Mandrup, S., Schlosser, A. G., Andersen, T. L., Sørensen, G. L., et al. (2020) · Hepatology · doi:10.1002/hep.31215 · Cited by 104 · see citing works

Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi

Xiong, X., Wang, Q., Wang, S., Zhang, J., Liu, T., Guo, L., Yu, Y., & Lin, J. D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.004 · Cited by 100 · see citing works

High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss

Siersbæk, M. S., Varticovski, L., Yang, S., Baek, S., Nielsen, R., Mandrup, S., Hager, G. L., Chung, J. H., & Grøntved, L. (2017) · Scientific Reports · doi:10.1038/srep40220 · Cited by 96 · see citing works

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Glass, O., Henao, R., Patel, K., Guy, C. D., Gruss, H. J., Syn, W., Moylan, C. A., Streilein, R. D., Hall, R. P., Diehl, A. M., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1237 · Cited by 95 · see citing works

Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor

Rose, A. J., Díaz, M. B., Reimann, A., Klement, J., Walcher, T., Krones, A., Strobel, O., Werner, J. M., Peters, A., Kleyman, A., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.010 · Cited by 94 · see citing works

Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease

Frades, I., Andréasson, E., Mato, J. M., Alexandersson, E., Matthiesen, R., & Martínez‐Chantar, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124544 · Cited by 86 · see citing works

iRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data

Madsen, J., Schmidt, S., Larsen, B. D., Loft, A., Nielsen, R., & Mandrup, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1365 · Cited by 74 · see citing works

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin

Dong, Q., Zhu, X., Dai, C., Zhang, X., Gao, X., Wei, J., Sheng, Y., Zheng, Y., Yu, J., Xie, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7016 · Cited by 72 · see citing works

Integrated analysis of motif activity and gene expression changes of transcription factorsPreprint

Madsen, J. G. S., Rauch, A., Hauwaert, E. L. V., Schmidt, S. F., Winnefeld, M., & Mandrup, S. (2017) · Genome Research · doi:10.1101/gr.227231.117 · Cited by 72 · see citing works

Krüppel-Like Zinc Finger Protein Glis2 Is Essential for the Maintenance of Normal Renal Functions

Kim, Y., Kang, H. S., Herbert, R., Beak, J. Y., Collins, J. B., Grissom, S. F., & Jetten, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01722-07 · Cited by 70 · see citing works

TSC22D4 is a molecular output of hepatic wasting metabolism

Jones, A., Friedrich, K., Rohm, M., Schäfer, M., Algire, C., Kulozik, P., Seibert, O., Müller‐Decker, K., Sijmonsma, T., Strzoda, D., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201869 · Cited by 63 · see citing works

Hepatic Deficiency in Transcriptional Cofactor TBL1 Promotes Liver Steatosis and Hypertriglyceridemia

Kulozik, P., Jones, A., Mattijssen, F., Rose, A. J., Reimann, A., Strzoda, D., Kleinsorg, S., Raupp, C., Kleinschmidt, J. A., Müller‐Decker, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.011 · Cited by 60 · see citing works

Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma

Feuchtinger, A., Stiehler, T., Jütting, U., Marjanović, G., Luber, B., Langer, R., & Walch, A. K. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-014-1258-2 · Cited by 57 · see citing works

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

Ægidius, H. M., Veidal, S. S., Feigh, M., Hallenborg, P., Puglia, M., Pers, T. H., Vrang, N., Jelsing, J., Kornum, B. R., Blagoev, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58059-7 · Cited by 51 · see citing works

Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver

Dubois, V., Gheeraert, C., Vankrunkelsven, W., Dubois‐Chevalier, J., Dehondt, H., Bobowski‐Gerard, M., Vinod, M., Zummo, F. P., Güiza, F., Ploton, M., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199156 · Cited by 46 · see citing works

Dynamic Transcriptional and Epigenetic Changes Drive Cellular Plasticity in the Liver

Merrell, A. J., Peng, T., Li, J., Sun, K., Li, B., Katsuda, T., Grompe, M., Tan, K., & Stanger, B. Z. (2021) · Hepatology · doi:10.1002/hep.31704 · Cited by 42 · see citing works

Transcriptome Analysis on the Inflammatory Cell Infiltration of Nonalcoholic Steatohepatitis in Bama Minipigs Induced by a Long-Term High-Fat, High-Sucrose Diet

Xia, J., Yuan, J., Xin, L., Zhang, Y., Kong, S., Chen, Y., Yang, S., & Li, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113724 · Cited by 34 · see citing works

Genome-Wide Insights into the Development and Function of Thermogenic Adipocytes

Loft, A., Forss, I., & Mandrup, S. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.005 · Cited by 28 · see citing works

Plasma proteome profiles treatment efficacy of incretin dual agonism in diet‐induced obese female and male mice

Sachs, S., Niu, L., Geyer, P. E., Jall, S., Kleinert, M., Feuchtinger, A., Stemmer, K., Brielmeier, M., Finan, B., DiMarchi, R. D., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14215 · Cited by 21 · see citing works

Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor

Sánchez‐Quiles, V., Akimov, V., Osinalde, N., Francavilla, C., Puglia, M., Barrio‐Hernandez, I., Kratchmarova, I., Olsen, J. V., & Blagoev, B. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.066423 · Cited by 15 · see citing works

A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver diseasePreprint

Niu, L., Thiele, M. S., Geyer, P. E., Rasmussen, D. N., Webel, H. E., Santos, A., Gupta, R., Meier, F., Strauss, M. T., Kjærgaard, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.16.337592 · Cited by 12 · see citing works

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430 · see citing works

Molecular mechanisms in MASLD/MASH-related HCC

Wang, X., Zhang, L., & Dong, B. (2024) · Hepatology · doi:10.1097/hep.0000000000000786 · Cited by 188 · see citing works

Epithelial–mesenchymal transition in tissue repair and degeneration

Youssef, K. K., & Nieto, M. A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00733-z · Cited by 162 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

Loss of liver function in chronic liver disease: An identity crisis

Berasain, C., Arechederra, M., Argemí, J., Fernández-Barrena, M. G., & Avila, M. A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.001 · Cited by 99 · see citing works

A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis

Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76 · see citing works

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems

Liu, J., Liu, J., Mu, W., Ma, Q., Zhai, X., Jin, B., Liu, Y., & Zhang, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c02380 · Cited by 74 · see citing works

Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis

Xiao, Y., Batmanov, K., Hu, W., Zhu, K., Tom, A. Y., Guan, D., Jiang, C., Cheng, L., McCright, S. J., Yang, E. C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9653 · Cited by 69 · see citing works

Liver regeneration: Cellular origin and molecular mechanisms

Huang, R. C. C., Zhang, X., Gracia‐Sancho, J., & Xie, W. (2022) · Liver International · doi:10.1111/liv.15174 · Cited by 68 · see citing works

Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma

Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C. J., Ramos‐Molina, B., & Gurzov, E. N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100811 · Cited by 60 · see citing works

Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity

Greatorex, S., Kaur, S., Xirouchaki, C. E., Goh, P. K., Wiede, F., Genders, A., Tran, M., Jia, Y., Raajendiran, A., Brown, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162533 · Cited by 50 · see citing works

Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines

Gong, L., Wei, F., Gonzalez, F. J., & Li, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000182 · Cited by 58 · see citing works

Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periostin

Xie, W., Gan, J., Zhou, X., Tian, H., Pan, X., Liu, W., Li, X., Du, J., Xu, A., Zheng, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.020 · Cited by 55 · see citing works

GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases

Li, Z., Zhang, H., Li, Q., Feng, W., Jia, X., Zhou, R., Huang, Y., Li, Y., Hu, Z., Hu, X., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02257-1 · Cited by 54 · see citing works

The role of N-glycosylation modification in the pathogenesis of liver cancer

Hu, M., Zhang, R., Yang, J., Zhao, C., Liu, W., Huang, Y., Lyu, H., Xiao, S., Guo, D. S., Zhou, C., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05733-z · Cited by 53 · see citing works

Spatial genomics: mapping human steatotic liver disease

Matchett, K. P., Paris, J., Teichmann, S. A., & Henderson, N. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00915-2 · Cited by 52 · see citing works

HNF4A modulates glucocorticoid action in the liver

Hunter, A. L., Poolman, T. M., Kim, D., Gonzalez, F. J., Bechtold, D. A., Loudon, A. S. I., Iqbal, M., & Ray, D. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110697 · Cited by 49 · see citing works

Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis

Zhang, L., Deng, W., Huang, Q., Zhang, J., Wang, Y., Zhou, T., Xing, L., & Jiang, H. (2024) · Advanced Materials · doi:10.1002/adma.202311474 · Cited by 47 · see citing works

Liver-specific actions of GH and IGF1 that protect against MASLD

Kineman, R. D., del Río-Moreno, M., & Waxman, D. J. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01037-0 · Cited by 39 · see citing works

IL6 supports long-term expansion of hepatocytes in vitro

Guo, R., Jiang, M., Wang, G., Li, B., Jia, X., Ai, Y., Chen, S., Tang, P., Liu, A., Yuan, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35167-8 · Cited by 36 · see citing works

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases

Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33 · see citing works

The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression

Wang, G., Duan, J., Pu, G., Ye, C., Li, Y., Xiu, W., Xu, J., Liu, B., Zhu, Y., & Wang, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166413 · Cited by 33 · see citing works

Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming

Aguilar‐Bravo, B., Ariño, S., Blaya, D., Pose, E., de la Torre, R. A. M. G., Latasa, M. U., Martínez–Sánchez, C., Zanatto, L., Sererols-Viñas, L., Vilà, P. C., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.013 · Cited by 32 · see citing works

Regulation of systemic metabolism by tissue-resident immune cell circuits

Li, J. H., Hepworth, M. R., & O’Sullivan, T. E. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.001 · Cited by 34 · see citing works

Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease

Pedersen, F. B., Akimov, V., Teuchler, M., Terkelsen, M. K., Wernberg, C. W., Larsen, F. T., Hallenborg, P., Lauridsen, M. M., Krag, A. A., Mandrup, S., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00780-3 · Cited by 30 · see citing works

Distinct hepatocyte identities in liver homeostasis and regeneration

Chen, F., Schönberger, K., & Tchorz, J. S. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100779 · Cited by 30 · see citing works

Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease

Zhang, C., Rehman, M., Tian, X., Pei, S. L. C., Gu, J., Bell, T. A., Dong, K., Tham, M. S., Cai, Y., Wei, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48025-6 · Cited by 30 · see citing works

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis

Zhang, J., Shen, Y., Chen, X.-Y., Jiang, M.-L., Yuan, F.-H., Xie, S.-L., Zhang, J., & Xu, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1115890 · Cited by 30 · see citing works

Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans

Pan, C., Liu, J., Gao, Y., Yang, M., Hu, H., Liu, C., Qian, M., Yuan, H.-Y., Yang, S., Zheng, M.-H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.018 · Cited by 27 · see citing works

Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging

Occean, J. R., Yang, N., Sun, Y., Dawkins, M. S., Munk, R. B., Belair, C., Dar, S. A., Anerillas, C., Wang, L., Shi, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50725-y · Cited by 27 · see citing works

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Das, S. R., Finney, A. C., Anand, S. K., Rohilla, S., Liu, Y., Pandey, N. O., Ghrayeb, A., Kumar, D., Núñez, K., Liu, Z., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01134-4 · Cited by 26 · see citing works

Hepatocyte survival and proliferation by fibroblast growth factor 7 attenuates liver inflammation, and fibrogenesis during acute liver injury via paracrine mechanisms

Geervliet, E., Terstappen, L. W. M. M., & Bansal, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115612 · Cited by 26 · see citing works

EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis

Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29 · see citing works

Lactate and lactylation: novel perspectives on fibrosis pathogenesis and therapeutic directions

Liang, H., Xu, L., & Yang, Y. A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06748-0 · Cited by 29 · see citing works

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression

Banerjee, A., & Farci, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168641 · Cited by 24 · see citing works

Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling

Li, Y., Xiu, W., Xu, J., Chen, X., Wang, G., Duan, J., Sun, L., Liu, B., Xie, W., Pu, G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.162402 · Cited by 23 · see citing works

Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia

Kaltenecker, D., Schmidt, S. F., Weber, P., Loft, A., Morigny, P., Machado, J., Geppert, J., Saul, K. B., Benedikt, P., Molocea, C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.039 · Cited by 23 · see citing works

ChemPert: mapping between chemical perturbation and transcriptional response for non-cancer cells

Zheng, M., Okawa, S., Bravo, M., Chen, F., Martínez‐Chantar, M. L., & del Sol, A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac862 · Cited by 23 · see citing works

Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death

Lambrecht, R., Delgado, M. E., Gloe, V., Schuetz, K., Plazzo, A. P., Franke, B., Phan, T. S., Fleming, J. R., Mayans, O. M., & Brunner, T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113513 · Cited by 23 · see citing works

The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models

Aki, D., Hayakawa, T., Srirat, T., Shichino, S., Ito, M., Saitoh, S.-I., Mise-Omata, S., & Yoshimura, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175305 · Cited by 22 · see citing works

GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation

Rizza, S., Leo, L. D., Pecorari, C., Giglio, P., Faienza, F., Montagna, C., Maiani, E., Puglia, M., Bosisio, F. M., Petersen, T. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.111997 · Cited by 20 · see citing works

Interrogating mechanisms of liver fibrosis with omics

Oakley, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00567-6 · Cited by 19 · see citing works

Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?

Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19 · see citing works

FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis

Wen, Y., Zou, Z.-Y., Zhao, G., Zhang, M., Zhang, Y., Wang, G., Shi, J., Wang, Y.-Y., Song, Y.-Y., Wang, H., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01329-1 · Cited by 18 · see citing works

Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk

Martins, M. C., Dixon, E. D., Lupo, G., Claudel, T., Trauner, M., & Rombouts, K. (2024) · Liver International · doi:10.1111/liv.16117 · Cited by 20 · see citing works

Cell competition in primary and metastatic colorectal cancer

van Luyk, M. E., García, A. K., Λάμπρου, Μ., & Suijkerbuijk, S. J. E. (2024) · Oncogenesis · doi:10.1038/s41389-024-00530-5 · Cited by 18 · see citing works

GLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease

Jetten, A. M., Scoville, D. W., & Kang, H. S. (2022) · Cells · doi:10.3390/cells11111833 · Cited by 17 · see citing works

Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease

Dubois, V., Lefèbvre, P., Staels, B., & Eeckhoute, J. (2024) · Gut · doi:10.1136/gutjnl-2023-331741 · Cited by 17 · see citing works

Unraveling DINCH – Induced hepatotoxicity mechanisms via network toxicology and molecular docking with experimental validation

Xin, J., Zhou, C., Wang, Y., Chen, H., Yin, K., Gao, L., & Shao, S. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118305 · Cited by 16 · see citing works

Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease

Ariño, S., Ferrer‐Lorente, R., Serrano, G., Zanatto, L., de la Torre, R. A. M. G., Gratacós‐Ginès, J., Rubio, A. B., Pérez-Guasch, M., Mateos-Sánchez, C., Aguilar‐Bravo, B., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.07.014 · Cited by 17 · see citing works

GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation

Zhang, H., Zhou, P., Xing, W., Chen, L., Zhou, Y., Yang, H., Fu, K., & Liu, Z. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.015 · Cited by 15 · see citing works

Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective

Fu, Y., Wang, Z., & Qin, H. (2024) · Metabolites · doi:10.3390/metabo14040218 · Cited by 15 · see citing works

CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion

Rho, H. K., Kim, S., Kim, S. U., Kim, J. W., Lee, S. H., Park, S., Escorcia, F. E., Chung, J., & Song, J. (2024) · Nature Communications · doi:10.1038/s41467-024-53002-0 · Cited by 15 · see citing works

Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression

Huerta, M., Franco-Serrano, L., Amela, I., Perez-Pons, J. A., Piñol, J., Mozo-Villarias, Á., Querol, E., & Cedano, J. A. (2023) · Cells · doi:10.3390/cells12020235 · Cited by 14 · see citing works

Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis

Karri, K., & Waxman, D. J. (2023) · RNA · doi:10.1261/rna.079580.123 · Cited by 14 · see citing works

Lack of thyroid hormone receptor beta is not detrimental for non-alcoholic steatohepatitis progression

López‐Alcántara, N., Oelkrug, R., Sentis, S. C., Kirchner, H., & Mittag, J. (2023) · iScience · doi:10.1016/j.isci.2023.108064 · Cited by 14 · see citing works

HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis

Yang, Y., Liu, X., Chen, H., Wang, P., Yao, S., Zhou, B., Yin, R., Li, C., Wu, C., Yang, X., et al. (2022) · FEBS Journal · doi:10.1111/febs.16430 · Cited by 14 · see citing works

Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma

Sun, Y.-D., Zhang, H., Li, Y., & Han, J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189086 · Cited by 13 · see citing works

Hydroxysteroid 17β‐dehydrogenase 13 ( Hsd17b13 ) knockdown attenuates liver steatosis in high‐fat diet obese mice

Mahmood, S., Morrice, N., Thompson, D., Milanizadeh, S., Wilson, S., Whitfield, P. D., Mcilroy, G. D., Rochford, J. J., & Mody, N. (2025) · Experimental Physiology · doi:10.1113/ep092535 · Cited by 13 · see citing works

Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice

Liu, T., Wang, Q., Zhou, L., Zhang, P., Mi, L., Qiu, X., Chen, Z., Kuang, H., Li, S., & Lin, J. D. (2022) · Hepatology · doi:10.1002/hep.32719 · Cited by 13 · see citing works

Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis

Beyoğlu, D., Huang, P., Skelton-Badlani, D., Zong, C., Popov, Y. V., & Idle, J. R. (2023) · Cells · doi:10.3390/cells12030485 · Cited by 12 · see citing works

Metabolism and bioenergetics in the pathophysiology of organ fibrosis

Miguel, V., Alcalde‐Estévez, E., Sirera, B., Rodríguez‐Pascual, F., & Lamas, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.001 · Cited by 12 · see citing works

The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche

Gonzalez‐Sanchez, E., Vaquero, J., Caballero‐Díaz, D., Grzelak, J., Fusté, N. P., Bertrán, E., Amengual, J., García‐Sáez, J., Martín‐Mur, B., Gut, M. O., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6299 · Cited by 12 · see citing works

Chemically induced revitalization of damaged hepatocytes for regenerative liver repair

Lin, P., Bai, Y., Nian, X.-X., Chi, J., Chen, T., Zhang, J., Zhang, W., Zhou, B., Liu, Y., & Zhao, Y. (2023) · iScience · doi:10.1016/j.isci.2023.108532 · Cited by 11 · see citing works

Purification of GFP-tagged nuclei from frozen livers of INTACT mice for RNA- and ATAC-sequencing

Loft, A., Herzig, S., & Schmidt, S. F. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100805 · Cited by 11 · see citing works

Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function

Wolff, G., Sakurai, M., Mhamane, A., Troullinaki, M., Maida, A., Deligiannis, I. K., Yin, K., Weber, P., Morgenstern, J., Wieder, A., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101487 · Cited by 12 · see citing works

Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice

Quitete, F. T., Teixeira, A. V. S., Peixoto, T. C., Martins, B. C., Atella, G. C., Resende, Â. C., Mucci, D. D. B., Martins, F. F., & Daleprane, J. B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308334 · Cited by 10 · see citing works

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163

Skytthe, M. K., Pedersen, F. B., Wernberg, C. W., Chandran, V. I., Krag, A. A., Caterino, T. D., Mandacaru, S. C., Blagoev, B., Lauridsen, M. M., Detlefsen, S., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.03.006 · Cited by 9 · see citing works

Emerging roles of RNA‐binding proteins in fatty liver disease

Adesanya, O. A., Das, D., & Kalsotra, A. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1840 · Cited by 9 · see citing works

TSC22D4 promotes TGFβ1-induced activation of hepatic stellate cells

Sakurai, M., Weber, P., Wolff, G., Wieder, A., Szendroedi, J., Herzig, S., & Üstünel, B. E. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.05.100 · Cited by 9 · see citing works

CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells

Calixto-Tlacomulco, S., Luna-Reyes, I., Delgado‐Coello, B., Gutiérrez‐Vidal, R., Reyes‐Grajeda, J. P., & Mas‐Oliva, J. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102937 · Cited by 9 · see citing works

Thwarting Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) with Common Bean: Dose- and Sex-Dependent Protection against Hepatic Steatosis

Lutsiv, T., McGinley, J. N., Neil, E. S., Foster, M. T., & Thompson, H. J. (2023) · Nutrients · doi:10.3390/nu15030526 · Cited by 9 · see citing works

Interdisciplinary advances reshape the delivery tools for effective NASH treatment

Chen, L., & Wang, Y. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101730 · Cited by 9 · see citing works

Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression

Sonkar, R., Ma, H., & Waxman, D. J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae057 · Cited by 7 · see citing works

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition

Shen, T. K., Vignane, T., Gilglioni, E. H., Traini, L., Kalaitsidou, E., Conan, P., Li, A., St‐Pierre‐Wijckmans, W., Herranz, J. M., Elvira, B., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103809 · Cited by 8 · see citing works

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Ye, B., Yu, M., Yue, M., Yin, M., Zhang, C., Wang, Q., Ding, X., Shen, W., & Zhao, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-38144-3 · Cited by 8 · see citing works

The chromatin remodeling protein BRG1 mediates Ang II induced pro-fibrogenic response in renal fibroblasts

Hong, W., Zhu, Y., Lin, Y., Tang, S., Chen, J., Xu, L., Jiang, J., Zong, Y., Zhang, Y., Sun, A., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122320 · Cited by 8 · see citing works

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Ntambi, J.-N., Kalyesubula, M., Cootway, D., Lewis, S. A., Phang, Y. X., Liu, Z., O’Neill, L. M., Lefers, L., Huff, H., Miller, J. R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159538 · Cited by 9 · see citing works

Dynamic enhancer interactome promotes senescence and agingPreprint

Wang, L., Donahue, G., Zhang, C., Havas, A. P., Lei, X., Xu, C., Wang, W., Vahedi, G., Adams, P. D., & Berger, S. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.22.541769 · Cited by 8 · see citing works

Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity

Pérez‐Schindler, J., Vargas‐Fernández, E., Karrer‐Cardel, B., Ritz, D., Schmidt, A., & Handschin, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-15731-4 · Cited by 7 · see citing works

An extended transcription factor regulatory network controls hepatocyte identity

Dubois‐Chevalier, J., Gheeraert, C., Berthier, A., Boulet, C., Dubois, V., Guille, L., Fourcot, M., Marot, G., Gauthier, K., Dubuquoy, L., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357020 · Cited by 6 · see citing works

Mesenchymal drift: A convergent framework for the hallmarks of aging

Lu, J. Y., Tu, W. B., Ma, S., Ma, Z., Imaz-Rosshandler, I., Weng, M., Qu, J., Esteban, C. R., Reddy, P., Liu, G.-H., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.020 · Cited by 10 · see citing works

Alterations in the hepatocyte epigenetic landscape in steatosis

Maji, R. K., Czepukojc, B., Scherer, M., Tierling, S., Cadenas, C., Gianmoena, K., Gasparoni, N., Nordström, K. J. V., Gasparoni, G., Laggai, S., et al. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00504-8 · Cited by 6 · see citing works

NHE1 regulation in NAFLD in vitro contributes to hepatocyte injury and HSC crosstalk

Sjøgaard-Frich, L. M., Henriksen, M. S., Lam, S., Birkbak, F. J., Czaplińska, D., Flinck, M., & Pedersen, S. F. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0099 · Cited by 6 · see citing works

Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis

Das, M., Savidge, B. O., Pearl, J. E., Yates, T. E., Miles, G. J., Pareek, M., Haldar, P., & Cooper, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012565 · Cited by 6 · see citing works

Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD

Dam, T. V., Toft, N. I., & Grøntved, L. (2022) · Cells · doi:10.3390/cells11050870 · Cited by 6 · see citing works

Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids

Sarıyar, E., & Karagonlar, Z. F. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231193421 · Cited by 6 · see citing works

High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model

Taguchi, D., Shirakami, Y., Sakai, H., Maeda, T., Miwa, T., Kubota, M., Imai, K., Ibuka, T., & Shimizu, M. (2024) · Nutrients · doi:10.3390/nu16152506 · Cited by 5 · see citing works

Nrf2 deficiency causes hepatocyte dedifferentiation and reduced albumin production in an experimental extrahepatic cholestasis model

Wang, G., Garcia, V., Lee, J., Yanum, J. A., Lin, J., Jiang, H., & Dai, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269383 · Cited by 5 · see citing works

Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy

Ma, M., Wang, X., Liu, X., Han, Y., Chu, Y., Guan, Y., & Liu, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01435-4 · Cited by 5 · see citing works

Targeted blockade of extracellular vesicles-mediated profibrotic vicious circle using EVs-based dual-drug delivery system to prevent liver fibrosis

Sun, J., Shen, Y., Wang, X., Men, R., Xing, X., Lv, L., Yang, F., Shen, M., Zheng, Y., Fan, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03940-8 · Cited by 4 · see citing works

Lipid-induced granules in hepatocytes alleviate liver fibrosis.

Li, Y., Lei, T., Nie, W., Ma, M.-R., Zhao, W., Zhou, Y., Liu, Y., Wang, M.-J., Jia, K.-W., Liu, S., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2025.12.015 · Cited by 4 · see citing works

Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesityPreprint

Hung, Y.-H., Sritharan, R., Vohl, M., Ilkayeva, O., Biertho, L. D., Tchernof, A., White, P. J., & Sethupathy, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.20.457162 · Cited by 4 · see citing works

Indirubin alleviates CCl4-induced liver fibrosis by regulation of TGF-β-mediated signaling pathways.

Li, X., Yao, Y., & Lin, W. (2023) · PubMed Central · doi:10.22038/ijbms.2023.70476.15319 · Cited by 3 · see citing works

Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes

Wada, T., Takeda, Y., Okekawa, A., Komatsu, G., Iwasa, Y., Onogi, Y., Takasaki, I., Hamashima, T., Sasahara, M., Tsuneki, H., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75713-6 · Cited by 3 · see citing works

The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease

Grandt, J., Johansen, C. D., Jensen, A. H., Werge, M. P., Rashu, E. B., Møller, A., Junker, A. E., Hobolth, L., Mortensen, C., Vyberg, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0307345 · Cited by 3 · see citing works

Dietary olive oil intake induces female-specific hepatic lipid accumulation without metabolic impairment in mice

Komiya, Y., Sugiyama, M., Koyama, C., Kameshima, S., Ochiai, M., Adachi, Y., Yokoyama, I., Fukasawa, H., Yoshioka, K., & Arihara, K. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.02.001 · Cited by 3 · see citing works

Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis

Wang, Y., Yu, H., Cen, Z., Zhu, Y., & Wu, W. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100267 · Cited by 3 · see citing works

In Silico Treatment: a computational framework for animal model selection and drug assessmentPreprint

Picart‐Armada, S., Becker, K., Kästle, M., Krenkel, O., Simon, E. S., Tenbaum, S. P., Strobel, B., Geillinger‐Kästle, K. E., Fundel‐Clemens, K., Matera, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.17.599264 · Cited by 3 · see citing works

Transcriptional factor RUNX1: A potential therapeutic target for fibrotic pulmonary disease

LIU, J., WANG, F., YUAN, B., & Luo, F. (2023) · Biocell · doi:10.32604/biocell.2023.026148 · Cited by 2 · see citing works

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis

Wang, Z.-Y., Keogh, A., Waldt, A., Cuttat, R., Neri, M., Zhu, S., Schuierer, S., Ruchti, A., Crochemore, C., Knehr, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98806-y · Cited by 103 · see citing works

Identification of NASH-associated signaling networks in murine hepatic stellate cells

Ravnskjær, K. (2017) · University of Southern Denmark Research Portal (University of Southern Denmark)

Understanding the cellular interactome of non-alcoholic fatty liver disease

Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116 · see citing works

Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review)

Zhou, X., Yang, C., Weng, Z., & 李立华 (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.6020

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95 · see citing works